Efficacy and Safety of Tranexamic Acid in Control of Bleeding Following TKR: A Randomized Clinical Trial

P N Kakar, Nishkarsh Gupta, Pradeep Govil, Vikram Shah, P N Kakar, Nishkarsh Gupta, Pradeep Govil, Vikram Shah

Abstract

Total knee arthroplasty (TKA) is generally carried out using a tourniquet and blood loss occurring mainly post operatively is collected in drains. Tranexamic acid is an antifibrinolytic agent which decreases the total blood loss. Patients had unilateral / bilateral cemented TKA using combined spinal and epidural anaesthesia. In a double-blind fashion, they received either placebo (n=25) or tranexamic acid (n=25)10 mg.kg(-1) i.v., just before tourniquet inflation, followed by 1 mg kg(-1) h-1 i.v. till closure of the wound. The postoperative blood loss, transfusion requirement, cost effectiveness and complications were noted. The groups had similar characteristics. The mean volume of drainage fluid was 270 ml and 620 ml for unilateral(U/L) and bilateral(B/L) TKR patients in placebo group. Whereas it was 160ml and 286 ml respectively in unilateral(U/L) and bilateral(B/L) TKR patients who received tranexamic acid. This was considered statistically significant. Control group patients received 26 units of PRBC as compared to 4 units in tranexamic acid groups (p<0.001). This was again statistically significant. None of the patients in any of the groups developed deep vein thrombosis. Tranexamic acid decreased total blood loss by nearly 54% in B/L TKR and 40% in U/L TKR and drastically reduced (> 80%) blood transfusion.

Keywords: TKR; Tranexamic acid; blood loss.

Figures

Fig 1
Fig 1
Effect of TAX on Postoperative Blood loss
Fig 2
Fig 2
Effect of TAX on Postoperative blood transfusions
Fig 3
Fig 3
Effect of TAX on postoperative Hb concentration

References

    1. Pier Mannuccio Mannuccio, Marcel Levi. Prevention and treatment of major blood loss. N Engl J Med. 2007;356:2301–11.
    1. Sculco TP, Adams GL, et al. Global blood management in orthopedic surgery. Clin Orthop Relat Res. 1998;357:43–49.
    1. Lisa Hall Zimmerman. Causes and consequences of critical bleeding and mechanism of blood coagulation. Pharmacotherapy. 2007;27:45S–56S.
    1. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty. A prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg [Br] 1996;78-B:434–440.
    1. Montserrat Vera-Llonch. Clinical and economic consequences of bleeding following major orthopedic surgery. Thrombosis Research. 2006;117:569–577.
    1. Cid, Lozano Tranexamic acid reduces allogenic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion. 2005;45:1302–07.
    1. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57:1005–32.
    1. Bekassy Z, Astedt B. Treatment with fibrinolytic inhibitor tranexamic acid – risk for thrombosis? Acta Obstet Gynecol Scand. 1990;69:353–54.
    1. Eriksson BI, Eriksson E, Risberg B. Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients. Thromb Res. 1991;62:55–64.
    1. Malone PC, Morris CJ. The sequestration and margination of platelets and leucocytes in veins during conditions of hypokinetic and anemic hypoxia. Potential significance in clinical postoperative venous thrombosis. J Pathol. 1978;125:119–29.
    1. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B. Anti-fibrinolytic use for minimizing perioperative allogenic blood transfusion (Review) Cochrane Database of Systematic Reviews. 2007;(Issue 4)

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する